1. Home
  2. DTI vs NSRX Comparison

DTI vs NSRX Comparison

Compare DTI & NSRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Drilling Tools International Corporation

DTI

Drilling Tools International Corporation

HOLD

Current Price

$2.83

Market Cap

76.7M

Sector

Industrials

ML Signal

HOLD

NSRX

Nasus Pharma Ltd. Ordinary Shares

N/A

Current Price

$6.70

Market Cap

63.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
DTI
NSRX
Founded
1984
2019
Country
United States
Israel
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
76.7M
63.4M
IPO Year
N/A
2025

Fundamental Metrics

Financial Performance
Metric
DTI
NSRX
Price
$2.83
$6.70
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$20.50
AVG Volume (30 Days)
113.5K
3.5K
Earning Date
11-06-2025
02-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$160,964,000.00
N/A
Revenue This Year
$3.41
N/A
Revenue Next Year
$1.30
N/A
P/E Ratio
N/A
N/A
Revenue Growth
7.46
N/A
52 Week Low
$1.43
$5.90
52 Week High
$3.82
$9.99

Technical Indicators

Market Signals
Indicator
DTI
NSRX
Relative Strength Index (RSI) 55.94 N/A
Support Level $2.70 N/A
Resistance Level $2.95 N/A
Average True Range (ATR) 0.25 0.00
MACD -0.01 0.00
Stochastic Oscillator 53.95 0.00

Price Performance

Historical Comparison
DTI
NSRX

About DTI Drilling Tools International Corporation

Drilling Tools International Corp manufactures, rents, inspects, and refurbishes downhole drilling tools primarily to companies in the oil and natural gas industry for bottom hole assemblies used in onshore and offshore horizontal and directional drilling. The company's United States operations have locations in Texas, California, Louisiana, Oklahoma, Pennsylvania, North Dakota, New Mexico, Utah, and Wyoming. The company's single segment derives revenues from customers by providing oilfield equipment and services to operators in the oil and natural gas sectors.

About NSRX Nasus Pharma Ltd. Ordinary Shares

Nasus Pharma Ltd is a clinical-stage specialty pharmaceutical company focused principally on the development of intranasal drugs to treat emergency medical conditions. It is engaged in developing a number of intranasal powder products based on its a microsphere technology, aimed at assisting patients in several acute emergency situations such as opioid overdose and anaphylactic shock. Its portfolio comprises a number of programs: Intranasal Naloxone completed pivotal study and Intranasal Epinephrine (phase 2) as well as a number of preclinical POC programs.

Share on Social Networks: